Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Monotherapies with nivolumab, pembrolizumab, and camrelizumab have shown increased survival rates in patients who failed to respond to first-line platinum-containing therapy.
First-line combination therapies with chemotherapy or immunotherapy are currently being investigated.
…